Novo Nordisk
Pharmaceuticals, health care
Based in DC
🤖
AI Overview
With $420K in lobbying spend across 10 quarterly filings, Novo Nordisk is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2018 to 2019.
$420K
Total Spend
2
Years Active
1
Firms Hired
4
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $160K |
| 2019 | $260K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Taxation, Pharmacy, Medicare/Medicaid, Health Issues
- •- Implementation of the Tax Cuts and Jobs Act (Pub.L. 115-97)
- •- Issues related to the 340B Drug Pricing Program, generally; 340B Protecting Access for the Underserved and Safety-Net Entities (340 PAUSE) Act (H.R. 4710)
- •- Issues related to the FDA Reauthorization
- •- Diabetes prevention, generally
- •- Implementation of the Clinical Care Commission Act (Pub.L. 115-80)
- •- World Hemophilia Day
- •- Issues related to medication affordability and access, generally
- •- Americ
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Association of Benefits and Insurance Professionals
$8.6M total spend
F Hoffmann-la Roche LTD and its Affiliates
$4.0M total spend
Biotechnology Industry Organization
$2.8M total spend
Blood Cancer United (Formerly Reported Asthe Leukemia and Lymphoma Society)
$1.8M total spend
Fresenius Kabi, LLC
$440K total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.